SCGN and STAT3 expressions are associated with the prognosis of ccRCC
- 10 November 2023
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 252, 154940
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 21 references indexed in Scilit:
- Comparative STAT3-Regulated Gene Expression Profile in Renal Cell Carcinoma SubtypesFrontiers in Oncology, 2019
- Clear cell renal cell carcinoma with wild‐type von Hippel‐Lindau gene: a non‐existent or new tumour entity?Histopathology, 2018
- Overexpression of secretagogin promotes cell apoptosis and inhibits migration and invasion of human SW480 human colorectal cancer cellsBiomedicine & Pharmacotherapy, 2018
- Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell CarcinomaTargeted Oncology, 2018
- Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete MetastasectomyEuropean Urology, 2018
- Variation in genomic landscape of clear cell renal cell carcinoma across EuropeNature Communications, 2014
- Expression of secretagogin in clear-cell renal cell carcinomas is associated with a high metastasis rateHuman Pathology, 2011
- Panel of Candidate Biomarkers for Renal Cell CarcinomaJournal of Proteome Research, 2010
- Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin AVirchows Archiv, 2006
- Activation of Signal Transducer and Activator of Transcription 3 in Renal Cell Carcinoma: A Study of Incidence and Its Association With Pathological Features and Clinical OutcomeJournal of Urology, 2002